Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | CFTR | P13569 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2376299 | 0.83 | ESR1 (0.35) | ALOX15TSHRALDH1A1MAPK1 | |
| SCHEMBL2268223 | 0.81 | CYP2A6 (0.50) | CYP2A6ALOX15CYP1A2HTR2ACA1 | |
| SCHEMBL11602636 | 0.81 | CYP2A6 (0.50) | CYP2A6ALOX15CYP1A2HTR2ACA1 | |
| SCHEMBL28606703 | 0.77 | CYP1A2 (0.46) | CYP2A6ALOX15CYP1A2HTR2AALOX5 | |
| SCHEMBL743489 | 0.77 | CYP1A2 (0.46) | CYP2A6ALOX15CYP1A2HTR2AALOX5 | |
| SCHEMBL3889506 | 0.77 | CYP1A2 (0.46) | CYP2A6ALOX15CYP1A2HTR2AALOX5 | |
| SCHEMBL1318871 | 0.77 | CYP1A2 (0.46) | CYP2A6ALOX15CYP1A2HTR2AALOX5 | |
| SCHEMBL20352831 | 0.77 | CYP2A6 (0.44) | CYP2A6ALOX15CYP1A2HTR2ACA1 | |
| SCHEMBL1986354 | 0.75 | IGF1R (0.43) | CYP2A6CYP1A2HTR2AALOX5 | |
| SCHEMBL241160 | 0.75 | IGF1R (0.43) | CYP2A6CYP1A2HTR2AALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1339733-B1 | METHOD FOR THE PRODUCTION OF 4-(17ALPHA-METHYL SUBSTITUTED 3-OXOESTRA-4,9-DIEN-11BETA-YL)BENZALDEHYD-(1E OR 1Z)-OXIMES | BAYER SCHERING PHARMA AG (DE) | 2008-08-13 | — | — | EP | claimed |
| EP-1339734-B1 | METHOD FOR THE PRODUCTION OF 4-(17ALPHA SUBSTITUTED 3-OXOESTRA-4,9-DIEN-11BETA-YL)BENZALDEHYD-(1E OR 1Z)-OXIMES | SCHERING AG (DE) | 2006-08-23 | — | — | EP | claimed |
| EP-1339733-A2 | METHOD FOR THE PRODUCTION OF 4-(17ALPHA-METHYL SUBSTITUTED 3-OXOESTRA-4,9-DIEN-11-YL)BENZALDEHYD-(1E OR 1Z)-OXIMES | Schering AG (DE) | 2003-09-03 | — | — | EP | claimed |
| EP-1339734-A2 | METHOD FOR THE PRODUCTION OF 4-(17ALPHA SUBSTITUTED 3-OXOESTRA-4,9-DIEN-11-YL)BENZALDEHYD-(1E OR 1Z)-OXIMES | Schering AG (DE) | 2003-09-03 | — | — | EP | claimed |
| WO-2002038582-A2 | METHOD FOR THE PRODUCTION OF 4-(17ALPHA SUBSTITUTED 3-OXOESTRA-4,9-DIEN-11-YL)BENZALDEHYD-(1E OR 1Z)-OXIMES | SCHERING AG (DE) | 2002-05-16 | — | — | WO | claimed |
| WO-2002038581-A2 | METHOD FOR THE PRODUCTION OF 4-(17ALPHA-METHYL SUBSTITUTED 3-OXOESTRA-4,9-DIEN-11BETA-YL)BENZALDEHYD-(1E OR 1Z)-OXIMES | SCHERING AG (DE) | 2002-05-16 | — | — | WO | claimed |
| EP-3252037-B1 | PROCESS FOR THE PREPARATION OF (3Z,5S)-5-(HYDROXYMETHYL)-1-[(2´-METHYL-1,1´-BIPHENYL-4-YL)CARBONYL)PYRROLIDIN-3-ONE O-METHYLOXIME | ObsEva SA (CH) | 2022-03-09 | — | — | EP | disclosed |
| CN-107721811-B | Side-fluorine-containing biphenyl diluent for high-birefringence liquid crystal and synthetic method thereof | 陕西师范大学 | 2021-01-29 | — | — | CN | disclosed |
| EP-3380101-B1 | EIF4-A-INHIBITING COMPOUNDS AND METHODS RELATED THERETO | EFFECTOR THERAPEUTICS INC (US) | 2021-01-27 | — | — | EP | disclosed |
| CN-109251189-B | 3-piperazinyl chalcone derivatives, pharmaceutical compositions thereof and application thereof | 华东理工大学 | 2020-10-02 | — | — | CN | disclosed |
| CN-109251189-A | 3 piperazinyl chalcone derivatives, its pharmaceutical composition and its application | 华东理工大学 | 2019-01-22 | — | — | CN | disclosed |
| EP-2818531-B1 | Polymerisable compounds and the use thereof in liquid-crystal displays | MERCK PATENT GMBH (DE) | 2017-07-26 | — | — | EP | disclosed |
| WO-2017091585-A1 | EIF4-A-INHIBITING COMPOUNDS AND METHODS RELATED THERETO | EFFECTOR THERAPEUTICS, INC. (US) | 2017-06-01 | — | — | WO | disclosed |
| WO-2002038582-A2 | METHOD FOR THE PRODUCTION OF 4-(17ALPHA SUBSTITUTED 3-OXOESTRA-4,9-DIEN-11-YL)BENZALDEHYD-(1E OR 1Z)-OXIMES | SCHERING AG (DE) | 2002-05-16 | — | — | WO | disclosed |
| WO-2002038581-A2 | METHOD FOR THE PRODUCTION OF 4-(17ALPHA-METHYL SUBSTITUTED 3-OXOESTRA-4,9-DIEN-11BETA-YL)BENZALDEHYD-(1E OR 1Z)-OXIMES | SCHERING AG (DE) | 2002-05-16 | — | — | WO | disclosed |
| EP-0648778-B1 | 11-Benzaldoximeestradiene-derivates, a process for their preparation and pharmaceutical compositions containing them | JENAPHARM GMBH (DE) | 1997-08-13 | — | — | EP | disclosed |
| EP-0648779-B1 | New 11-benzaldehyde oxime, 17-beta methoxy, 17 alpha methoxymethyl derivates of estradiene, a process for their preparation and pharmaceutical compositions containing them | JENAPHARM GMBH (DE) | 1997-03-05 | — | — | EP | disclosed |
| EP-0648779-A2 | New 11-benzaldehyde oxime, 17-beta methoxy, 17 alpha methoxymethyl derivates of estradiene, a process for their preparation and pharmaceutical compositions containing them | JENAPHARM GmbH (DE) | 1995-04-19 | — | — | EP | disclosed |
| EP-0648778-A2 | 11-Benzaldoximeestradiene-derivates, a process for their preparation and pharmaceutical compositions containing them | JENAPHARM GmbH (DE) | 1995-04-19 | — | — | EP | disclosed |
| EP-0052836-A1 | Phenoxybenzaldehydes and process for their preparation | HOECHST AKTIENGESELLSCHAFT (DE) | 1982-06-02 | — | — | EP | disclosed |